Neogen Corp (NEOG) — SEC Filings
Neogen Corp (NEOG) — 42 SEC filings. Latest: 8-K (Apr 20, 2026). Includes 22 8-K, 7 10-Q, 4 SC 13G/A.
Overview
Neogen Corp (NEOG) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Apr 9, 2026: NEOGEN CORP filed its quarterly report (10-Q) on April 9, 2026, for the period ending February 28, 2026. The filing includes various documents related to its financial reporting, such as the iXBRL 10-Q document and exhibits like certifications and a graphic image. NEOGEN CORP is based in Lansing, MI
Sentiment Summary
Across 42 filings, the sentiment breakdown is: 1 bullish, 1 bearish, 37 neutral, 3 mixed. The dominant filing sentiment for Neogen Corp is neutral.
Filing Type Overview
Neogen Corp (NEOG) has filed 22 8-K, 7 10-Q, 3 8-K/A, 2 DEF 14A, 2 10-K, 2 SC 13G, 4 SC 13G/A with the SEC between Jan 2024 to Apr 2026.
Filings by Year
Recent SEC Filings (42)
Risk Profile
Risk Assessment: Of NEOG's 35 recent filings, 0 were flagged as high-risk, 10 as medium-risk, and 25 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $209,189,000 |
| Net Income | $36,338,000 |
| EPS | $0.17 |
| Debt-to-Equity | 0.37 |
| Cash Position | $138,883,000 |
| Operating Margin | 45.40% |
| Total Assets | $3,378,156,000 |
| Total Debt | $792,530,000 |
Key Executives
- Mike Nassif
- Amy M. Rocklin
- David E. Smith
- Dr. Steven L. Smith
- Dr. David A. Smith
- Dr. Steven L. Klink
- Dr. David E. MacLean
Industry Context
Neogen operates in the animal health and food safety sectors, which are characterized by increasing demand for diagnostics, testing, and biosecurity solutions driven by global food production, regulatory requirements, and consumer safety concerns. The industry is competitive, with players focusing on innovation, product breadth, and global reach. Trends include advancements in genomic testing, rapid diagnostics, and integrated solutions for farm-to-fork safety.
Top Tags
corporate-governance (8) · financials (7) · amendment (6) · 10-Q (5) · financial-reporting (5) · governance (5) · officer-changes (4) · executive-compensation (4) · board-changes (4) · sec-filing (4)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| iXBRL 10-Q Size | 2683903 | Size of the interactive data filing |
| Complete Submission Text File Size | 11854441 | Size of the full submission text |
| Net Income | $36.338M | Swung from a $12.609M net loss in Q1 2024, primarily due to divestiture gain. |
| Gain on Sale of Business | $76.390M | Key driver of net income, from the sale of the C&D business to Kersia Group. |
| Total Revenues | $209.189M | Decreased by 3.59% from $216.964M in Q1 2024. |
| Operating Loss | $16.091M | Compared to an operating income of $2.257M in Q1 2024, indicating core operational challenges. |
| Cash and Cash Equivalents | $138.883M | Increased from $129.004M at May 31, 2025, partly due to divestiture proceeds. |
| Non-Current Debt | $792.530M | Reduced by $82.280M from $874.810M at May 31, 2025. |
| Basic Net Income Per Share | $0.17 | Improved from a basic net loss per share of $0.06 in Q1 2024. |
| Common Stock Outstanding | 217,298,626 | As of August 31, 2025. |
| Annual Meeting Date | October 23, 2025 | Date of Neogen's 2025 Annual Meeting of Shareholders |
| Record Date | August 26, 2025 | Date for determining shareholders eligible to vote at the Annual Meeting |
| Meeting Start Time | 10:00 a.m. Eastern Time | Scheduled start time for the virtual Annual Meeting |
| Class II Directors | 4 | Number of Class II directors to be elected for three-year terms |
| Shares Outstanding | 217,298,626 | Total shares of common stock outstanding as of the record date |
Forward-Looking Statements
- {"claim":"Neogen's stock price may experience minor downward pressure due to Vanguard's reduced stake.","entity":"Neogen Corp","targetDate":"Q1 2024","confidence":"low"}
- {"claim":"Other institutional investors may re-evaluate their positions in Neogen Corp. following Wasatch Advisors LP's reduction below the 5% threshold.","entity":"Neogen Corp.","targetDate":"Q2 2024","confidence":"medium"}
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Neogen Corp (NEOG)?
Neogen Corp has 42 recent SEC filings from Jan 2024 to Apr 2026, including 22 8-K, 7 10-Q, 4 SC 13G/A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of NEOG filings?
Across 42 filings, the sentiment breakdown is: 1 bullish, 1 bearish, 37 neutral, 3 mixed. The dominant sentiment is neutral.
Where can I find Neogen Corp SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Neogen Corp (NEOG) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Neogen Corp?
Key financial highlights from Neogen Corp's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for NEOG?
The investment thesis for NEOG includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Neogen Corp?
Key executives identified across Neogen Corp's filings include Mike Nassif, Amy M. Rocklin, David E. Smith, Dr. Steven L. Smith, Dr. David A. Smith and 2 others.
What are the main risk factors for Neogen Corp stock?
Of NEOG's 35 assessed filings, 0 were flagged high-risk, 10 medium-risk, and 25 low-risk.
What are recent predictions and forward guidance from Neogen Corp?
Recent forward-looking statements from Neogen Corp include guidance on {"claim":"Neogen's stock price may experience minor downward pressure due to Vanguard's reduced stake.","entity":"Neogen and 1 other predictions.